CN1053589C - Chinese medicine Pingguxiaociwan for curing Bi-syndrome - Google Patents

Chinese medicine Pingguxiaociwan for curing Bi-syndrome Download PDF

Info

Publication number
CN1053589C
CN1053589C CN 97122390 CN97122390A CN1053589C CN 1053589 C CN1053589 C CN 1053589C CN 97122390 CN97122390 CN 97122390 CN 97122390 A CN97122390 A CN 97122390A CN 1053589 C CN1053589 C CN 1053589C
Authority
CN
China
Prior art keywords
radix
medicine
chinese
present
chinese patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 97122390
Other languages
Chinese (zh)
Other versions
CN1183986A (en
Inventor
侯忠义
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 97122390 priority Critical patent/CN1053589C/en
Publication of CN1183986A publication Critical patent/CN1183986A/en
Application granted granted Critical
Publication of CN1053589C publication Critical patent/CN1053589C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a Chinese patent medicine for treating arthromyodynia, which is characterized in that the present invention is prepared from fifteen Chinese herbal medicines of angelica, milkvetch root, white peony alba, solomonseal rhizomes, hemlock parsley, safflower, frankincense, myrrh, eucommia bark, Chinese taxillus herbs, matrimony vines, doubleteeth pubesscent angelica root, largeleaf gentian roots, clematis root and fresh ginger. With the advantages of full mixing, high scientificalness and complete treatment, the present invention has the efficacy of tonifying Qi to benefit kidney, promoting blood circulation to stop pain, expelling pathogenic cold from channel and relaxing muscles and tendons, and accords with the pathogenesis of Chinese medicine theories to the arthromyodynia. The present invention also has the advantages of convenient operation, few toxic and side effects and high curative effects (effective rate can reach 96.3%).

Description

The Chinese patent medicine " Pingguxiaoci pill " of treatment arthromyodynia
The invention belongs to the medicine of treatment arthromyodynia, be specifically related to kind of the Chinese patent medicine of treatment arthromyodynia.
The record of arthromyodynia in TCM Document, see the earliest " element is asked. the numbness opinion " and, " wet three gas of wind and cold are assorted extremely, close and be numbness ", " so-called numbness person, each in the wet gas of wind and cold also " with reinfection at that time.Therefore, the traditional Chinese medical science is thought arthromyodynia mainly due to positive QI-insufficiency, experiences due to wind, cold, wet, the hot heresy.
Modern medicine is observed in clinical, the scope that arthromyodynia comprises is very extensive, symptoms such as all arthralgias, enlargement distortion, joint joint stuffiness are all classified the arthromyodynia category as, therefore, in conjunction with modern medicine, it can comprise rheumatism atrophic arthritis, diseases such as the arthralgia that gout, hyperosteogeny cause, sciatica and hyperplastic spondylitis.Because human body is suffered from similar symptom is all arranged when stating disease, thus the sickness rate of arthromyodynia can't accurately estimate, only be example with the rheumatoid arthritis, China's prevalence is about 1 ‰ (" commonly encountered diseases tcm clinical practice therapeutic advances ", China Chinese medicine publishing house published 93 pages in 1991).
Doctor trained in Western medicine generally adopts salicylic acid preparation or hormonotherapy to above-mentioned treatment of diseases, but the undesirable dawn side effect of effect is bigger, is the problem that contemporary medical science circle is paid close attention to so inquire into tcm therapy.
Purpose of the present invention aims to provide the Chinese patent medicine of a kind of good effect, treatment arthromyodynia that toxic and side effects is little.
For reaching above-mentioned purpose, solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of Chinese medicine to arthromyodynia, consulted in a large number document at all times, again through clinical research for many years, from motherland's medical treasure-house, filter out tonify Qi of the kidney, the Chinese herbal medicine of promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening, by traditional Chinese medical science prescription theory, be prepared into oral Chinese patent medicine.
Theory of Chinese medical science thinks, arthromyodynia owing to wind, cold, wet, heat is assorted is the exopathogenic factor of assertive evidence to causing a disease, still, " institute of heresy gathers, its gas must void ", in the human righteousness lost, exopathogen can be invaded.Therefore, it will be argued that, tonify Qi of the kidney, promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening, is the main rule of treatment primary disease, also is the basic foundation of prescription, meets the generation and the law of development of primary disease.
The raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are (b is Unit Weight part):
Radix Angelicae Sinensis 35-45b Radix Astragali 55-65b Radix Paeoniae Alba 30-40b Rhizoma Polygonati 25-35b
Rhizoma Chuanxiong 25-35b Flos Carthami 15-21b Olibanum 17-23b Myrrha 17-23b
Cortex Eucommiae 35-45b Herba Taxilli 20-30b Fructus Lycii 25-35b Radix Angelicae Pubescentis 25-35b
Radix Gentianae Macrophyllae 25-35b Radix Clematidis 25-35b Rhizoma Zingiberis Recens 25-35b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Pharmaceutical analysis:
Radix Angelicae Sinensis among the above-mentioned side, the Radix Astragali, Rhizoma Polygonati, Fructus Lycii, the Radix Paeoniae Alba for tonify Qi of the kidney, nourshing Yin and drynsessmoistening prescription product, but Radix Astragali human body immunity improving function wherein, Fructus Lycii contains several amino acids and the endocrine regulation effect is arranged (referring to " Chinese medicine modern study and clinical practice ", the Xueyuan Press, nineteen ninety-five publishes, 478 pages); Rhizoma Chuanxiong, Flos Carthami, Olibanum, Myrrha are medicine for promoting blood circulation and dispelling blood stasis, can improve to be equipped with blood microcirculation in the body, reach the pain relieving purpose by invigorating blood circulation; The Cortex Eucommiae, Herba Taxilli, Radix Gentianae Macrophyllae, Radix Clematidis dredge the meridian passage, the damp eliminating bone strengthening, wherein the Cortex Eucommiae contains eucommoil and multiple organic acid, the immunologic function that is significantly improved and anti-stress effect; Radix Angelicae Pubescentis has the effect of inducing sweat, and is the main separation medicine of treatment rheumatalgia; Rhizoma Zingiberis Recens has dispelling cold by warming the meridian, anti-inflammatory analgesic action.Full side's compatibility, scientific strong, treating both the principal and secondary aspects of a disease, can reach tonify Qi of the kidney, the effect of promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening.
Efficacy analysis:
The inventor once treated thousands of routine arthromyodynia patients with this medicine, all received satisfactory effect to improving its symptom, and the elite 300 complete example statistics of record material of selecting are as follows:
Rheumatism, rheumatoid arthritis pain Produce effects 53 Progressive 67 Invalid 4 Subtotal 124
Gout 9 13 2 24
The arthralgia that hyperosteogeny and intervertebral disk hernia cause 33 40 3 76
The numb limbs and tense tendons that a variety of causes causes, handicapped 26 16 0 42
Other 18 14 2 34
Amount to 139 (46.3%) 150 (50%) 11 (3.7%) 300
By above statistics as can be known, this medicine total effective rate is 96.3%, and except that gout, symptom such as the arthralgia that a variety of causes is caused, numb limbs and tense tendons, activities adverse all has satisfactory effect.
Model case:
Example one, Li Zhirong, man, 65 years old, area just outside a city gate town, Xia County, Shanxi Province retired worker.
Because of the working environment humidity, suffered from rheumatic arthritis before more than ten years, both legs pain, morning, deadlock was more serious when day cold, can not normal activity, the influence life.Once used the Western medicine pain relieving, DeGrain comes the court to go to a doctor February 18 nineteen ninety-five, looks into patient's moving difficulty, and right leg joint is swollen to rise, patient's poor appetite, and lustreless complexion, white and thin fur, thready and rapid pulse gives Chinese patent medicine of the present invention then, every day twice, each 1 ball, yellow wine takes.Month state of an illness of taking medicine just has improvement, and diet strengthens, and pain relief was taken medicine two months again, and the state of an illness is almost recovered, can activity freely, efficacy consolidation half a year is followed up a case by regular visits in the work that does housework followingly.
Example two, Wang Xiaoyi, man, 34 years old, Weinan, the Shaanxi Province building workman of team.
Because of before 3 years during work waist injured, not radical cure, morbidity repeatedly in recent years, lumbago reflexes to shank at ordinary times, sits the difficulty that crouches, handicapped, the state of an illness increased the weight of afterwards, can not work, once the x of hospital ray examination was diagnosed as prolapse of lumbar intervertebral disc.Come the court's treatment on July 28th, 1994, give Chinese patent medicine of the present invention at once, take medicine twice every day, each ball, the medication two weeks state of an illness greatly takes a turn for the better, and pain relief was taken medicine again one month, and the state of an illness is almost recovered, can operate as normal.
Chinese patent medicine treating both the principal and secondary aspects of a disease of the present invention, scientific strong, easy to use, toxic and side effects is little, curative effect height (effective percentage reaches 96.3%), full side's compatibility reach tonify Qi of the kidney, the effect of promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening.
Embodiment one, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is (b is Unit Weight part):
Radix Angelicae Sinensis 40b Radix Astragali 60b Radix Paeoniae Alba 35b Rhizoma Polygonati 30b
Rhizoma Chuanxiong 30b Flos Carthami 18b Olibanum 20b Myrrha 20b
Cortex Eucommiae 40b Herba Taxilli 25b Fructus Lycii 30b Radix Angelicae Pubescentis 30b
Radix Gentianae Macrophyllae 30b Radix Clematidis 30b Rhizoma Zingiberis Recens 30b
Method for making: above-mentioned 15 flavor medicines are chosen decontamination earlier, well sifted, and pulverization is made honeyed pill promptly with the first-class Mel mixing of equivalent, and every ball weighs and 9 restrains (pill quality should meet " the Chinese medicine pill prescription that Chinese pharmacopoeia is contained).
Usage, consumption: oral, every day twice, each half ball-1 ball, the normal or blood pressure person on the low side of blood pressure joins yellow wine one or two when taking medicine.
Function: tonify Qi of the kidney promoting blood circulation and stopping pain, dispelling cold by warming the meridian, channels sootheing and network vessel quickening.
Cure mainly: various arthralgia due to wind-cold-dampness disease, as rheumatism, rheumatoid arthritis, the arthralgia that prolapse of lumbar intervertebral disc, hyperosteogeny etc. causes, the muscle arteries and veins is arrested curved, numb limbs and tense tendons, it is difficult to take action, joint stuffiness etc.
Embodiment two, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is (b is Unit Weight part):
Radix Angelicae Sinensis 35b Radix Astragali 55b Radix Paeoniae Alba 30b Rhizoma Polygonati 25b
Rhizoma Chuanxiong 25b Flos Carthami 15b Olibanum 17b Myrrha 17b
Cortex Eucommiae 35b Herba Taxilli 20b Fructus Lycii 25b Radix Angelicae Pubescentis 25b
Radix Gentianae Macrophyllae 25b Radix Clematidis 25b Rhizoma Zingiberis Recens 25b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Embodiment three, and the weight proportion of the raw material of Chinese medicine of Chinese patent medicine of the present invention is (b is Unit Weight part):
Radix Angelicae Sinensis 45b Radix Astragali 65b Radix Paeoniae Alba 40b Rhizoma Polygonati 35b
Rhizoma Chuanxiong 35b Flos Carthami 21b Olibanum 23b Myrrha 23b
Cortex Eucommiae 45b Herba Taxilli 30b Fructus Lycii 35b Radix Angelicae Pubescentis 35b
Radix Gentianae Macrophyllae 35b Radix Clematidis 35b Rhizoma Zingiberis Recens 35b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.

Claims (2)

1, the Chinese patent medicine of treatment arthromyodynia is characterized in that: the raw material of Chinese medicine of Chinese patent medicine of the present invention and weight proportion are (b is Unit Weight part):
Radix Angelicae Sinensis 35-45b Radix Astragali 55-65b Radix Paeoniae Alba 30-40b Rhizoma Polygonati 25-35b
Rhizoma Chuanxiong 25-35b Flos Carthami 15-21b Olibanum 17-23b Myrrha 17-23b
Cortex Eucommiae 35-45b Herba Taxilli 20-30b Fructus Lycii 25-35b Radix Angelicae Pubescentis 25-35b
Radix Gentianae Macrophyllae 25-35b Radix Clematidis 25 35b Rhizoma Zingiberis Recens 25-35b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, the Chinese patent medicine of treatment arthromyodynia according to claim 1 is characterized in that: the weight proportion of described raw material of Chinese medicine is (b is Unit Weight part):
Radix Angelicae Sinensis 40b Radix Astragali 60b Radix Paeoniae Alba 35b Rhizoma Polygonati 30b
Rhizoma Chuanxiong 30b Flos Carthami 18b Olibanum 20b Myrrha 20b
Cortex Eucommiae 40b Herba Taxilli 25b Fructus Lycii 30b Radix Angelicae Pubescentis 30b
Radix Gentianae Macrophyllae 30b Radix Clematidis 30b Rhizoma Zingiberis Recens 30b
CN 97122390 1997-12-18 1997-12-18 Chinese medicine Pingguxiaociwan for curing Bi-syndrome Expired - Fee Related CN1053589C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97122390 CN1053589C (en) 1997-12-18 1997-12-18 Chinese medicine Pingguxiaociwan for curing Bi-syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97122390 CN1053589C (en) 1997-12-18 1997-12-18 Chinese medicine Pingguxiaociwan for curing Bi-syndrome

Publications (2)

Publication Number Publication Date
CN1183986A CN1183986A (en) 1998-06-10
CN1053589C true CN1053589C (en) 2000-06-21

Family

ID=5176819

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97122390 Expired - Fee Related CN1053589C (en) 1997-12-18 1997-12-18 Chinese medicine Pingguxiaociwan for curing Bi-syndrome

Country Status (1)

Country Link
CN (1) CN1053589C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101028504B (en) * 2007-03-29 2010-05-19 任开益 Gubiping instant granules and production thereof
CN103893309B (en) * 2013-11-28 2015-12-09 鹤壁职业技术学院 A kind of medicine for the treatment of rheumatoid arthritis
CN104547633B (en) * 2014-12-25 2018-01-23 四川德峰药业有限公司 A kind of Chinese medicine composition for treating cervical spondylopathy and preparation method thereof
CN104826056A (en) * 2015-05-11 2015-08-12 宋宜德 Traditional Chinese medicine for treating rheumatism bone pain of lower limbs
CN107812075A (en) * 2017-11-24 2018-03-20 郭涤尘 A kind of capsule for treating gout
CN114246899A (en) * 2021-11-30 2022-03-29 湖南省开元博物馆 Wind-expelling and cold-dispelling medicine for treating muscle and bone pain and preparation method thereof

Also Published As

Publication number Publication date
CN1183986A (en) 1998-06-10

Similar Documents

Publication Publication Date Title
CN100450526C (en) Chinese medicinal formulation for treating rheumatic and rheumatoid disease
CN1250276C (en) Drug for curing disease of proplapse of lumbar intervertebral disc
CN1390585A (en) Chinese medicine for detoxication purpose and its preparing process
CN103055278A (en) Medicament for treating rheumatism
CN1053589C (en) Chinese medicine Pingguxiaociwan for curing Bi-syndrome
CN101690768B (en) Vein and artery relieving pills for impediment of sinew
CN1124156C (en) Chinese-medicinal pills for treating rheumatism and preparing process thereof
CN103251766A (en) Chinese medicine composition, and clinical preparation and preparation method thereof
CN1843421A (en) Rheumatoid disease treating medicine
CN101632745A (en) Traditional Chinese medical compound preparation for treating rheumatism and rheumatoid arthritis
CN1879749A (en) Medicinal heath wine
CN103861004A (en) Traditional Chinese medicine external application agent for treating knee osteoarthritis and nursing method
CN1151814C (en) Composite Chinese medicine for treating rheumatic Bi syndrome
CN1864735A (en) A Chinese medicine for treating hyperosteogeny and preparation method thereof
CN102872252B (en) Medicinal composition for treating rheumatic pain
CN102133380B (en) Medicament for treating cervical spondylosis
CN104740450A (en) Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder
CN1119161C (en) Medicine for treating rheumatisms
CN1299748C (en) Fat reducing regulating Qi supplement bag
CN106421514A (en) Traditional Chinese medicine for treating arthralgia
CN1308952A (en) Chinese medicine for treating trigeminal neuraligia and its preparing process
CN105687917A (en) Oral solution for treating arthritis
CN104857489A (en) Medicinal preparation for curing periarthritis of shoulder
CN112494547A (en) A granule for treating rheumatism and its preparation method
CN103656523A (en) Traditional Chinese medicine tablet capable of relaxing meridian and activating blood circulation and preparation method of tablet

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee